(Q79852066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Prostate-specific antigen velocity and prostate cancer gleason grade and stage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1

Paul F Pinsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Gerald Andriole

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

E David Crawford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

David Chia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Barnett S Kramer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Robert Grubb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Robert Greenlee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

John K Gohagan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1689-1695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Does PSA velocity predict prostate cancer in pre-screened populations?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Effect of ejaculation on serum total and free prostate-specific antigen concentrations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22558

7 January 2021

Identifiers

DOI

10.1002/CNCR.22558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17330856%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference